MedPath

Outcomes of Colonoscopy With Non-anesthesiologist Administered Propofol

Not Applicable
Completed
Conditions
ADR
Colo-rectal Cancer
Colon Adenoma
Interventions
Procedure: Sedation directed by an anesthesiologist
Procedure: Sedation directed by an endoscopist
Registration Number
NCT03922074
Lead Sponsor
Serveis de Salut Integrats Baix Empordà
Brief Summary

The Efficacy and safety of Non-anesthesiologist administered propofol (NAAP) for gastrointestinal endoscopy have been widely documented although there is not information which has evaluated the outcomes of colonoscopy it self when the endoscopist has to fulfill the additional task of supervising the sedation.

Objective: To determine the equivalence of adenoma detection rate (ADR) in colorectal cancer (CRC) screening colonoscopies performed with NAAP and performed with monitored anesthesia care (MAC).

Method: Single blind non-randomized controlled equivalence trial. Patients: Adults between 50 - 69 years old from National CRC screening program (CRCSP). Intervention: The patients are blindly assigned to undergo either colonoscopy with NAAP or MAC according to the arrival of fecal occult blood test, patient's suitability for colonoscopy date and availability of places at endoscopy schedule (with NAAP or MAC).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
630
Inclusion Criteria

Healthy patients -

Exclusion Criteria

Patients with familial colorectal cancer history

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Monitored anesthesia careSedation directed by an anesthesiologistSedation directed by an anesthesiologist in which the used intravenous drugs and target level sedation are chosen by the anesthesiologist.
Non-anesthesiologist administered propofolSedation directed by an endoscopistSedation directed by an endoscopist in which the intravenous drugs are propofol and fentanyl . Target level sedation: moderate - deep.
Primary Outcome Measures
NameTimeMethod
Adenoma detection rate30 days

Percentage of patients aged ≥50 years undergoing first-time screening colonoscopy who have one or more conventional adenomas detected and removed

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath